Clinical utility of cerebrovascular reactivity mapping in patients with low grade gliomas

doi:10.5306/wjco.v2.i12.397

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4777)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

470

HTML

3710

Figures (1-4)

382

Tables (1-2)

215

Sum=4777

Dec 10, 2011 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (60)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Clin Oncol. Dec 10, 2011; 2(12): 397-403
Published online Dec 10, 2011. doi: 10.5306/wjco.v2.i12.397

Full Size Figure Download Figure

Figure 3 Cerebrovascular reactivity ratio (n_CVR) (A) cerebral blood volume ratio (n_CBV) (B) and cerebral blood flow ratio (n_CBF) (C) distribution for the group of seven patients with classified grade I and grade II tumors included in this study. In all cases n_CVR is less than 1.0 and the median value is significantly less than 1.0 according to the one sample Wilcoxon test. n_CBV and n_CBF median values are not significantly lower or higher than 1.0.

Citation: Pillai JJ, Zacá D. Clinical utility of cerebrovascular reactivity mapping in patients with low grade gliomas. World J Clin Oncol 2011; 2(12): 397-403
URL: https://www.wjgnet.com/2218-4333/full/v2/i12/397.htm
DOI: https://dx.doi.org/10.5306/wjco.v2.i12.397